emcardioНеотложная кардиология и кардиоваскулярные рискиEmergency Cardiology and Cardiovascular Risks journal2616-633XБелорусский государственный медицинский университетemcardio-193Research ArticleОригинальные научные публикацииOriginal Scientific ResearchФакторы кардиоваскулярного риска в предоперационном и отдаленном послеоперационном периоде у реципиентов трансплантата почкиCardiovascular risk factors of preoperative and long-term postoperative period in kidney transplant recipientsСмоляковаМ. В.SmaliakovaM. V.ГригоренкоЕ. А.GrigorenkoE. A.КалачикО. В.KalachikO. V.МитьковскаяН. П.MitkovskayaN. P.Белорусский государственный медицинский университетBelarusГУ «Минский научно-практический центр хирургии, трансплантологии и гематологии»Belarus20203010202541846852Copyright © Смолякова М.В., Григоренко Е.А., Калачик О.В., Митьковская Н.П., 20252025Смолякова М.В., Григоренко Е.А., Калачик О.В., Митьковская Н.П.Smaliakova M.V., Grigorenko E.A., Kalachik O.V., Mitkovskaya N.P.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://emcardio.bsmu.by/jour/article/view/193

Цель: выявить факторы кардиоваскулярного риска у реципиентов трансплантата почки, а также изучить особенности лабораторно-инструментальных показателей в отдаленном послеоперационном периоде в зависимости от его течения и возникновения неблагоприятных кардиоваскулярных событий.

The aim of the study is to identify cardiovascular risk factors in kidney transplant recipients and to analyze the laboratory and instrumental findings of the long-term postoperative period depending on its course and the occurrence of adverse cardiovascular events.

реципиенты трансплантата почкинеблагоприятные кардиоваскулярные событияартериальная гипертензиядислипидемиягиперэритропоэтинемияkidney transplant recipientsadverse cardiovascular eventsarterial hypertensiondyslipidemiahypererythropoietinemiaReferencesPugh D., Gallacher P.J., Dhaun N. Management of Hypertension in Chronic Kidney Disease. Drugs, 2019, vol. 79, no 4, pp. 365-379.Pugh D., Gallacher P.J., Dhaun N. Management of Hypertension in Chronic Kidney Disease. Drugs, 2019, vol. 79, no 4, pp. 365-379.Assimon M.M., Wang L., Flythe J.E. Intradialytic hypertension frequency and shortterm clinical outcomes among individuals receiving maintenance hemodialysis. Am J Hypertens, 2018, vol. 31, pp. 329-339.Assimon M.M., Wang L., Flythe J.E. Intradialytic hypertension frequency and shortterm clinical outcomes among individuals receiving maintenance hemodialysis. Am J Hypertens, 2018, vol. 31, pp. 329-339.Li Z., Lacson Jr.E., Lowrie E.G., Ofsthun N.J., Kuhlmann M.K., Lazarus J.M., Levin N.W. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis, 2006, vol. 48, pp. 606-615.Li Z., Lacson Jr.E., Lowrie E.G., Ofsthun N.J., Kuhlmann M.K., Lazarus J.M., Levin N.W. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis, 2006, vol. 48, pp. 606-615.Ponticelli C., Cucchiari D., Graziani G. Hypertension in kidney transplant recipients. Transpl Int, 2011, vol. 24, no. 6, pp. 523-533.Ponticelli C., Cucchiari D., Graziani G. Hypertension in kidney transplant recipients. Transpl Int, 2011, vol. 24, no. 6, pp. 523-533.Kasiske B.L., Anjum S., Shah R., Skogen J., Kandaswamy C., Danielson B., O’Shaughnessy E.A., Dahl D.C., Silkensen J.R., Sahadevan M., Snyder J.J. Hypertension after kidney transplantation. Am J Kidney Dis, 2004, vol. 43, no. 6, pp. 1071-1081.Kasiske B.L., Anjum S., Shah R., Skogen J., Kandaswamy C., Danielson B., O’Shaughnessy E.A., Dahl D.C., Silkensen J.R., Sahadevan M., Snyder J.J. Hypertension after kidney transplantation. Am J Kidney Dis, 2004, vol. 43, no. 6, pp. 1071-1081.Cano N. Nutrition de l’hémodialysé chronique. Nutr Clin et Metab, 2004, vol. 18, no. 1, pp. 7-10.Cano N. Nutrition de l’hémodialysé chronique. Nutr Clin et Metab, 2004, vol. 18, no. 1, pp. 7-10.Tran M.-H., Foster C.E., Kalantar-Zadeh K., Ichii H. Kidney transplantation in obese patients. World J. Transplant, 2016, vol. 6, no. 1, pp. 135-143.Tran M.-H., Foster C.E., Kalantar-Zadeh K., Ichii H. Kidney transplantation in obese patients. World J. Transplant, 2016, vol. 6, no. 1, pp. 135-143.Gore J.L., Pham P.T., Danovitch G.M., Wilkinson A.H., Rosenthal J.T., Lipshutz G.S., Singer J.S. Obesity and outcome following renal transplantation. Am J Translant, 2006, vol. 6, pp. 357-363.Gore J.L., Pham P.T., Danovitch G.M., Wilkinson A.H., Rosenthal J.T., Lipshutz G.S., Singer J.S. Obesity and outcome following renal transplantation. Am J Translant, 2006, vol. 6, pp. 357-363.Lentine K.L., Rocca-Rey L.A., Bacchi G., Wasi N., Schmitz L., Salvalaggio P.R., Abbott K.C., Mark A.S., Neri L., Brennan D.C. Obesity and cardiac risk af ter kidney transplantation: experience at one center and comprehensive literature review. Transplantation, 2008, vol. 86, no. 2, pp. 303-312.Lentine K.L., Rocca-Rey L.A., Bacchi G., Wasi N., Schmitz L., Salvalaggio P.R., Abbott K.C., Mark A.S., Neri L., Brennan D.C. Obesity and cardiac risk af ter kidney transplantation: experience at one center and comprehensive literature review. Transplantation, 2008, vol. 86, no. 2, pp. 303-312.Heng A.E. Aniort J., Pereira B., Fervenza F., Boirie Y., Prieto M. Renal Transplant in Obese Patients and Impact of Weight Loss Before Surgery on Surgical and Medical Outcomes: A Single-Center Cohort Study. Exp Clin Transplant, 2019, vol. 17, no. 5, pp. 604-612.Heng A.E. Aniort J., Pereira B., Fervenza F., Boirie Y., Prieto M. Renal Transplant in Obese Patients and Impact of Weight Loss Before Surgery on Surgical and Medical Outcomes: A Single-Center Cohort Study. Exp Clin Transplant, 2019, vol. 17, no. 5, pp. 604-612.Nishizawa Y., Shoji T., Ishimura E., Inaba M., Morii H. Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia? Am J Kidney Dis, 2001, vol. 38, no. 4, pp. 4-7.Nishizawa Y., Shoji T., Ishimura E., Inaba M., Morii H. Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia? Am J Kidney Dis, 2001, vol. 38, no. 4, pp. 4-7.Devine P.A., Courtney A. E., Maxwell A. P. Cardiovascular risk in renal transplant recipients. J Nephrology, 2019, vol. 32, pp. 389-399.Devine P.A., Courtney A. E., Maxwell A. P. Cardiovascular risk in renal transplant recipients. J Nephrology, 2019, vol. 32, pp. 389-399.Jie K.E., Verhaar M.C., Cramer M.-J.M., van der Putten K., Gaillard C.A.J.M., Doevendans P.A., Koomans H.A., Joles J.A., Braam B. Erythropoietin and the cardiorenal syndrome: Cellular mechanisms on the cardiorenal connectors. Am J Renal Physiol, 2006, vol. 291, pp. 932-944.Jie K.E., Verhaar M.C., Cramer M.-J.M., van der Putten K., Gaillard C.A.J.M., Doevendans P.A., Koomans H.A., Joles J.A., Braam B. Erythropoietin and the cardiorenal syndrome: Cellular mechanisms on the cardiorenal connectors. Am J Renal Physiol, 2006, vol. 291, pp. 932-944.Palazzuoli A., Silverberg D.S., Iovine F., Calabrò A., Campagna M.S., Gallotta M., Nuti R. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome. Am Heart J, 2007, vol. 154, no. 645, pp. 9-15.Palazzuoli A., Silverberg D.S., Iovine F., Calabrò A., Campagna M.S., Gallotta M., Nuti R. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome. Am Heart J, 2007, vol. 154, no. 645, pp. 9-15.Ichimaru N., Obi Y., Nakazawa S., Yamanaka K., Kakuta Y., Abe T., Kaimori J.-Y., Imamura R., Nonomura N., Moriyama T., Takahara S. Post-transplant anemia has strong influences on renal and patient outcomes in living kidney transplant patients. Transplant Proc, 2016, vol. 48, no. 3, pp. 878-883.Ichimaru N., Obi Y., Nakazawa S., Yamanaka K., Kakuta Y., Abe T., Kaimori J.-Y., Imamura R., Nonomura N., Moriyama T., Takahara S. Post-transplant anemia has strong influences on renal and patient outcomes in living kidney transplant patients. Transplant Proc, 2016, vol. 48, no. 3, pp. 878-883.Kolonko A., Pinocy-Mańdok J., Kocierz M., Kujawa-Szewieczek A., Chudek J., Malyszko J., Malyszko J.S., Myśliwiec M., Wiecek A. Anemia and erythrocytosis after kidney transplantation and 5-year graft function and survival. Transplant Proc, 2009, vol. 41, no. 8, pp. 3046-3051.Kolonko A., Pinocy-Mańdok J., Kocierz M., Kujawa-Szewieczek A., Chudek J., Malyszko J., Malyszko J.S., Myśliwiec M., Wiecek A. Anemia and erythrocytosis after kidney transplantation and 5-year graft function and survival. Transplant Proc, 2009, vol. 41, no. 8, pp. 3046-3051.Malyszko J., Oberbauer R., Watschinger B. Anemia and erythrocytosis in patients after kidney transplantation. Transpl Int, 2012, vol. 25, no. 10, pp. 1013-1023.Malyszko J., Oberbauer R., Watschinger B. Anemia and erythrocytosis in patients after kidney transplantation. Transpl Int, 2012, vol. 25, no. 10, pp. 1013-1023.Wanner C., Zimmermann J., Schwedler S., Metzger T. Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl, 2002, vol. 80, pp. 99-102.Wanner C., Zimmermann J., Schwedler S., Metzger T. Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl, 2002, vol. 80, pp. 99-102.Zhang W., He J., Zhang F., Huang C., Wu Y., Han Y., Zhang W., Zhao Y. Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis. J Nephrol, 2013, vol. 26, no. 2, pp. 243-253.Zhang W., He J., Zhang F., Huang C., Wu Y., Han Y., Zhang W., Zhao Y. Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis. J Nephrol, 2013, vol. 26, no. 2, pp. 243-253.Smaliakova M.V., Mitkovskaya N.P., Kalachik O.V., Kartun L.V. Faktory kardiovaskulyarnogo riska u retsipiyentov transplantata pochki v rannem posleoperatsionnom periode. Neotlozhnaya kardiologiya i kardioovaskulyarnyye riski [Cardiovaccular risk factors in renal transplant recipients in the early postoperative period]. Neotlozhnaya kardiologiya i kardiovaskulyarnye riski, 2019, vol. 3, no. 1, pp. 513-518. (in Russian).Smaliakova M.V., Mitkovskaya N.P., Kalachik O.V., Kartun L.V. Faktory kardiovaskulyarnogo riska u retsipiyentov transplantata pochki v rannem posleoperatsionnom periode. Neotlozhnaya kardiologiya i kardioovaskulyarnyye riski [Cardiovaccular risk factors in renal transplant recipients in the early postoperative period]. Neotlozhnaya kardiologiya i kardiovaskulyarnye riski, 2019, vol. 3, no. 1, pp. 513-518. (in Russian).Abedini S., Holme I., März W., Weihrauch G., Fellström B., Jardine A., Cole E., Maes B., Neumayer H.-H., Grønhagen-Riska C., Ambühl P., Holdaas H. Inflammation in Renal Transplantation. Clin J Am Soc Nephrol, 2009, vol. 4, no. 7, pp. 1246-1254.Abedini S., Holme I., März W., Weihrauch G., Fellström B., Jardine A., Cole E., Maes B., Neumayer H.-H., Grønhagen-Riska C., Ambühl P., Holdaas H. Inflammation in Renal Transplantation. Clin J Am Soc Nephrol, 2009, vol. 4, no. 7, pp. 1246-1254.Bakri R.S., Afzali B., Covic A., Sriskantharan R., Bharma-Ariza P., Park W.-H., Sriharan M., Dalton N., Wierzbicki A.S., Crook M.A., Goldsmith D.J.A. Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation. Clin Transplant, 2004, vol. 18, no. 2. pp. 201-204.Bakri R.S., Afzali B., Covic A., Sriskantharan R., Bharma-Ariza P., Park W.-H., Sriharan M., Dalton N., Wierzbicki A.S., Crook M.A., Goldsmith D.J.A. Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation. Clin Transplant, 2004, vol. 18, no. 2. pp. 201-204.

The authors declare that there are no conflicts of interest present.